Business Context and Reporting Period
Company: Inmed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 13, 2021
Reporting Period: Third Quarter of Fiscal Year 2021 (ended March 31, 2021)
Item Reported: Regulation FD Disclosure regarding financial results.
Key Financial Metrics
The provided filing text serves as a cover document referencing a news release (Exhibit 99.1) but does not contain specific financial data tables or values. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. It only confirms that financial results for 3Q21 were reported.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of 3Q21 financial results but does not include specific commentary, guidance, or outlook statements within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (News Release dated May 13, 2021) for the actual financial figures and detailed commentary referenced in this 8-K.
- Verify the specific revenue, net loss, and cash position for the quarter ended March 31, 2021, as these are not listed in the cover document.
- Check for any forward-looking statements or updated guidance included in the full news release.